Osama Zaidat MD

Stroke & Interventional Neurology. Neuroscience & Stroke Director, Mercy Health. Ischemic & hemorrhagic stroke research.

[Aditya S. Pandey @Aditya_S_Pandey]

Congratulations Dr Marc Moisi and @MINeuroSurgeons for a great Neurosurgery meeting. Great to see colleagues @umichneuro presenting their work! Congratulations to all for a fantastic gathering!

[Galaxy Therapeutics @GalaxyThera]

Investing in emerging talent is investing in the future of MedTech.
We proudly recognize Galaxy Therapeutics’ Intern Class of 2025–2026 for their curiosity, commitment and contributions.
Thank you, Amy, Sophia, Eddie, Krish, Henry and Maya!
#FutureTalent #MedTech

[Osama Zaidat MD @oozaidat]

@GalaxyThera Galaxy is excited in welcoming our distributors and physicians at ESMINT to the first reception after the CE Mark approval.

[Galaxy Therapeutics @GalaxyThera]

Galaxy Reception - Marseille
Join us on September 3 at 16:30 during #ESMINT2026 as we celebrate the European launch of the SEAL™ Embolization System.

Attendance is limited.

RSVP ↓

https://t.co/PCshCH04u1

Marseille, here we go! 🇫🇷

#GalaxyReception #Neurointervention

[Osama Zaidat MD @oozaidat]

An amazing day in the Galaxy journey! 🚀 We got our CE mark, reflecting the dedication of our GT team and close to 500 patients worldwide.
Excited to partner with EU & global interventionalists to bring the SEAL to their toolbox! 🧠✨

[Osama Zaidat MD @oozaidat]

@GalaxyThera An amazing day in the Galaxy journey! 🚀 We got our CE mark, reflecting the dedication of our GT team and close to 500 patients worldwide.
Excited to partner with EU & global interventionalists to bring the SEAL to their toolbox! 🧠✨

[Galaxy Therapeutics @GalaxyThera]

Galaxy Therapeutics has achieved CE Mark for the SEAL™ Embolization System—enabling commercial launch across Europe and international markets.

A major milestone in expanding access to innovative brain aneurysm treatment.

Read more: https://t.co/Etd4ANi3fh

[Osama Zaidat MD @oozaidat]

@GalaxyThera Huge milestone for Galaxy! 🚀 Wrapping up our rigorous FDA Pre-Approval Inspection (PAI) this week is a massive step for our startup.
A direct testament to our team's hard work, long hours, and commitment to compliance, safety, and quality. Proud of the team! 👏

[Galaxy Therapeutics @GalaxyThera]

Another important milestone on our journey toward FDA approval.

This week, we welcomed the FDA for another key inspection at our Milpitas HQ.

We’d like to recognize and thank our R&D, Engineering, Manufacturing, Quality, Operations, and MedX CRO teams.

#GalaxyTherapeutics

[Osama Zaidat MD @oozaidat]

@GalaxyThera Looking forward to connecting with physicians

[Chris Pierzchalski @chrispy011]

@GalaxyThera @oozaidat Congrats @oozaidat and everyone involved. Huge accomplishment by a great team.

[Mohammad AlMajali @Mo_majali91]

Here we go- Congratulations @oozaidat and team 🔥

[Amit Chaudhari MD @NeuroIRdoc]

Love it ❤️ 💪

Thank you @SVINJournal for highlighting our paper 🙏

@ZRosensteinMED
@Mo_majali91
@AshouriYazan
@oozaidat

[NeuroNews @NN_publishing]

.@GalaxyThera has announced the submission of the final module of its PMA application to the @US_FDA for the Seal device for the treatment of wide-neck bifurcation aneurysms
@oozaidat
https://t.co/YUCr3bhBYM

[Yazan Ashouri @AshouriYazan]

Innovation is key in care of stroke patients @NeuroIRdoc @oozaidat @Mo_majali91

[Yazan Ashouri @AshouriYazan]

@SVINJournal @oozaidat @Mo_majali91 @NeuroIRdoc Can we update the graphic abstract because this is not the correct one @SVINJournal

[PICASSO Clinical Trial @ThePICASSOTrial]

Congrats and thank you to Dr. @dockhandelwal, Dr. Amit Singla, Dr. Fadar Otite, Dr. Nemanja Novakovic, Dr. @NaderElSeblani and the entire @RutgersU team for enrolling their 5th subject in the #PICASSO trial! 🎉🎉 @oozaidat @samialkasab @NguyenThanhMD

[PICASSO Clinical Trial @ThePICASSOTrial]

Congrats and thank you to Dr. @DrMichaelLevitt, Dr. Melanie Walker, Dr. @Steph_ChenMD, Dr. Basavaraj Ghodke and the entire @UW team for enrolling their debut subject in the #PICASSO trial! 🎉 @oozaidat @samialkasab @NguyenThanhMD

[PICASSO Clinical Trial @ThePICASSOTrial]

Congrats and thank you to Dr. Saad Hasan, Dr. @drjoshabecassis and the entire @uofl team for enrolling their 3rd subject in the #PICASSO trial! 🎉 @oozaidat @samialkasab @NguyenThanhMD

[PICASSO Clinical Trial @ThePICASSOTrial]

Congrats and thank you to Dr. Amer Alshekhlee, Dr. Chizoba Ezepue, and the entire @SSMHealth team for enrolling their 5th subject in the #PICASSO trial! 🎉 #ClinicalTrial #stroke @oozaidat @samialkasab @NguyenThanhMD